2014 Proxy Statement
Medgenics 2013 Annual Report

Investor Presentation: Mar. 2014

Sept 16, 2013
Medgenics Announces New Executive Leadership Team

ESGCT 2013
Second Generation EPODURE Biopump markedly extends duration of EPO delivery in mice, could prolong therapeutic effect in patients


Medgenics Sustained Protein Therapy

Medgenics is a clinical-stage biopharmaceutical company developing a proprietary technology for the sustained production and delivery of therapeutic proteins using ex-vivo gene therapy and the patientís own tissue for the treatment of orphan and rare diseases.